“The New Yorker” chronicles new approach in Alzheimer’s research

In a June 24, 2013 article, “Before Night Falls: Alzheimer’s researchers seek a new approach,” The New Yorker interviews Reisa Sperling, MD, director of the Alzheimer’s clinical research center at Bringham and Women’s Hospital and Massachusetts General Hospital in Boston. The article outlines a new study, the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease Trial (or A4 Trial), which Dr. Sperling and Paul Aisen, MD, of the University of California, San Diego will jointly oversee. The study, funded by the National Institutes of Health, aims at targeting beta-amyloid plaques in patients with pre-clinical Alzheimer’s disease in order to slow the accumulation of these plaques in the brain, and the symptoms of Alzheimer’s, before they start.

Read full article here

Comments are closed.